Birgit Schinzel

443 total citations
11 papers, 322 citations indexed

About

Birgit Schinzel is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Birgit Schinzel has authored 11 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 2 papers in Surgery and 1 paper in Molecular Biology. Recurrent topics in Birgit Schinzel's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Respiratory and Cough-Related Research (2 papers) and Inhalation and Respiratory Drug Delivery (2 papers). Birgit Schinzel is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Respiratory and Cough-Related Research (2 papers) and Inhalation and Respiratory Drug Delivery (2 papers). Birgit Schinzel collaborates with scholars based in Germany, Canada and Italy. Birgit Schinzel's co-authors include Martin Kolb, Manuel Quaresma, Susanne Stowasser, Luca Richeldi, Fernando J. Martínez, Athol U. Wells, S. Jouneau, Wim Wuyts, Ganesh Raghu and Jürgen Behr and has published in prestigious journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and Clinical Therapeutics.

In The Last Decade

Birgit Schinzel

9 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Schinzel Germany 4 293 95 39 25 21 11 322
Lawrence McDermott United States 4 253 0.9× 81 0.9× 30 0.8× 27 1.1× 22 1.0× 7 281
Magdalena Martusewicz-Boros Poland 8 165 0.6× 149 1.6× 39 1.0× 29 1.2× 15 0.7× 38 231
Zohra Carton France 5 234 0.8× 119 1.3× 14 0.4× 20 0.8× 24 1.1× 10 265
Valeria C. Amatto Germany 4 342 1.2× 147 1.5× 32 0.8× 11 0.4× 23 1.1× 5 357
Giulia Pelaia Italy 9 108 0.4× 162 1.7× 20 0.5× 7 0.3× 43 2.0× 20 240
Adelle S. Jee Australia 7 181 0.6× 47 0.5× 10 0.3× 89 3.6× 9 0.4× 16 207
W. Ennis James United States 6 145 0.5× 167 1.8× 16 0.4× 5 0.2× 28 1.3× 21 199
S. Jaffré France 8 74 0.3× 32 0.3× 7 0.2× 13 0.5× 13 0.6× 13 151
Pauli Pöyhönen Finland 9 138 0.5× 171 1.8× 17 0.4× 4 0.2× 27 1.3× 23 336
Christena A. Kolakowski United States 6 158 0.5× 156 1.6× 77 2.0× 6 0.2× 45 2.1× 10 270

Countries citing papers authored by Birgit Schinzel

Since Specialization
Citations

This map shows the geographic impact of Birgit Schinzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Schinzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Schinzel more than expected).

Fields of papers citing papers by Birgit Schinzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Schinzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Schinzel. The network helps show where Birgit Schinzel may publish in the future.

Co-authorship network of co-authors of Birgit Schinzel

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Schinzel. A scholar is included among the top collaborators of Birgit Schinzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Schinzel. Birgit Schinzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Torrisi, Sebastiano Emanuele, Marlies Wijsenbeek, Manuel Quaresma, et al.. (2020). Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Subgroup Analyses by TORVAN Stage. A1508–A1508. 1 indexed citations
2.
Richeldi, Luca, Martin Kolb, S. Jouneau, et al.. (2020). Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis. BMC Pulmonary Medicine. 20(1). 3–3. 69 indexed citations
3.
Τzouvelekis, Αrgyris, Toby M. Maher, Nicole Goh, et al.. (2020). Monocyte count and decline in forced vital capacity (FVC) in patients with IPF. 721–721.
4.
Behr, Jürgen, Martin Kolb, Jin Woo Song, et al.. (2019). Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis and Right Heart Dysfunction. A Prespecified Subgroup Analysis of a Double-Blind Randomized Clinical Trial (INSTAGE). American Journal of Respiratory and Critical Care Medicine. 200(12). 1505–1512. 49 indexed citations
5.
6.
Pfeifer, Michael, Martin Kolb, Athol U. Wells, et al.. (2019). Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis (IPF): the INSTAGE trial. Pneumologie. 1 indexed citations
7.
Cottin, Vincent, Martin Kolb, Antje Prasse, et al.. (2019). Nintedanib Plus Sildenafil in Patients with IPF and Severely Impaired Gas Exchange: Subgroup Analysis by Presence of Emphysema. A4082–A4082. 1 indexed citations
8.
Kolb, Martin, Athol U. Wells, Luca Richeldi, et al.. (2018). Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis. New England Journal of Medicine. 379(18). 1722–1731. 184 indexed citations
9.
Kolb, Martin, Athol U. Wells, Jürgen Behr, et al.. (2018). Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis (IPF): the INSTAGE trial. OA546–OA546. 2 indexed citations
11.
Chitwarakorn, Anupong, et al.. (1992). Treatment of Acute Gonococcal Infections in Bangkok with a Dose Range of the New Cephalosporin, Cefodizime. International Journal of STD & AIDS. 3(2). 111–116. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026